![Paradoxical psoriatic arthritis in a patient with psoriasis treated with guselkumab - Carriero - 2022 - Clinical and Experimental Dermatology - Wiley Online Library Paradoxical psoriatic arthritis in a patient with psoriasis treated with guselkumab - Carriero - 2022 - Clinical and Experimental Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/834977d6-4251-4cfa-868f-6f5eccf2146a/ced15061-fig-0001-m.jpg)
Paradoxical psoriatic arthritis in a patient with psoriasis treated with guselkumab - Carriero - 2022 - Clinical and Experimental Dermatology - Wiley Online Library
![Signaling pathways in rheumatoid arthritis: implications for targeted therapy | Signal Transduction and Targeted Therapy Signaling pathways in rheumatoid arthritis: implications for targeted therapy | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-023-01331-9/MediaObjects/41392_2023_1331_Fig1_HTML.png)
Signaling pathways in rheumatoid arthritis: implications for targeted therapy | Signal Transduction and Targeted Therapy
![Psoriatic arthritis: the role of the nonphysician clinician in the diagnosis and treatment of patients with psoriasis | Drugs & Therapy Perspectives Psoriatic arthritis: the role of the nonphysician clinician in the diagnosis and treatment of patients with psoriasis | Drugs & Therapy Perspectives](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40267-021-00814-5/MediaObjects/40267_2021_814_Fig1_HTML.jpg)
Psoriatic arthritis: the role of the nonphysician clinician in the diagnosis and treatment of patients with psoriasis | Drugs & Therapy Perspectives
![Colchicine twice a day for hand osteoarthritis (COLOR): a double-blind, randomised, placebo-controlled trial - The Lancet Rheumatology Colchicine twice a day for hand osteoarthritis (COLOR): a double-blind, randomised, placebo-controlled trial - The Lancet Rheumatology](https://www.thelancet.com/cms/asset/57414211-82ba-4b9e-91b0-57c4d0761676/gr1.jpg)